Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 7 Results

Title
Intervention Indication Therapeutic Area Year Actions
Semaglutide for overweight individuals ATB200/AT2221 , Semaglutide (Ozempic) Obesity , Weight management Endocrine Nutritional and Metabolic Disorders 2020 View  |  Download
Semaglutide for treating overweight and obesity Semaglutide (Ozempic) Obesity Endocrine Nutritional and Metabolic Disorders 2022 View  |  Download
Semaglutide for treating overweight and obesity in adolescents ages 12 to 17 years old Semaglutide (Ozempic) Obesity Endocrine Nutritional and Metabolic Disorders 2022 View  |  Download
Semaglutide for treating overweight or obesity with cardiovascular disease Semaglutide (Ozempic) Cardiovascular disease (CVD) , Obesity Cardiovascular System , Endocrine Nutritional and Metabolic Disorders 2023 View  |  Download
Setmelanotide for obesity in Bardet-Biedl syndrome and Alstrom syndrome Setmelanotide (RM-493) Hyperphagia , Obesity Endocrine Nutritional and Metabolic Disorders , Gastroenterology , Genetic Disorders 2021 View  |  Download
Setmelanotide for treating obesity caused by rare genetic disorders in children aged 2 to 6 years Setmelanotide (RM-493) Obesity Endocrine Nutritional and Metabolic Disorders 2022 View  |  Download
Tirzepatide for treating obese or overweight adults Tirzepatide (LY3298176) Obesity Cardiovascular System , Ear Nose and Throat (ENT) 2022 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications